InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: None

Monday, 05/26/2014 12:04:53 PM

Monday, May 26, 2014 12:04:53 PM

Post# of 426566
Pfizer Abandons AstraZeneca Takeover Bid After Rejection

'... The regulations require a cooling-off period of at least three months before talks can restart ... For talks to begin anew after three months, AstraZeneca must invite the discussion. Otherwise, Pfizer needs to wait six months to make a new bid ...'

' ... AstraZeneca may seek a revenue-generating acquisition of its own to help it fend off the larger company ... “The probability of a future AstraZeneca acquisition is dimmed, but not entirely extinguished,” said Mark Purcell, an analyst with Barclays Plc, in a note to clients. ... AstraZeneca Chairman Leif Johansson said in a statement after Pfizer’s announcement. “We have attractive growth prospects and a rapidly progressing pipeline. In the coming months, we anticipate positive news flow across our core therapeutic areas, which underpins our confidence in the long-term prospects of the business.”'


http://www.businessweek.com/news/2014-05-25/pfizer-said-on-verge-of-abandoning-astrazeneca-offer

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News